Global Market Study on Smart Pills: North America to Remain Most Remunerative Market for Smart Pills during 2017 - 2026


Smart Pills Market
  • Published On : Jan-2018 |
  • Pages : 170 Pages |
  • Format :

Persistence Market Research has developed an exclusive forecast study on global smart pills market, tracking the evolution of smart pills in the recent past and delivering valuable insights on its near future. The report provides objective analysis of smart pills as an emerging commodity in the global healthcare marketplace. Factors enabling smart pills to gain global recognition as miniaturized medical devices that can effectively monitor drug intake of patients have been analyzed in the report. A holistic overview of the global smart pills market has been delivered in the study, and key developments with respect to production of smart pills have been categorically studied to ascertain the future prospects.

Report Highlights

This report offers comprehensive analysis on the expansion of the global smart pills market for the forecast period, 2017-2026. Market size estimations for this period have been assessed by interpreting them across metrics such as annual (Y-o-Y) growth rates, compound annual growth rates, absolute dollar opportunities, and BPS index. A series of chapters and sub-sections containing first-hand information have been compiled together for developing this study.

Initially, the report offers an executive summary which abridges the most important findings from the analysis. This section reveals the leading segments in the global smart pills market. Following the executive summary, a chapter on the global smart pills market overview provides information of key segments and sub-segments. The section provides analysis for cost structure, pricing, regulatory guidelines, FDA approvals, raw material procurement strategies, and supply chain encompassing the production and sales of smart pills.

Industry trends influencing the dynamic growth of the global smart pills market have been identified. The report has studied the impact of these trends in influencing the strategies of manufacturers. Considering the evolution of smart pills, new production techniques surfacing the market have been identified. These methods, whether tested or prototypical, are being gauged with respect to their abilities in facilitating high-quality and large-scale production of smart pills. The report further exploits available knowledge databases to procure information on how more smart technologies can be integrated into these pills. Moreover, the study also reveals investments of market players towards production of the fragile sensors and trackers embedded inside smart pills.

Market Taxonomy

The report has segmented the global smart pills market on the basis of application, target area, and region. Country-specific market size analysis is also provided in the report. Distinct chapters on cross-segmental analysis are also a key highlight of the study.

Region

Application

Target Area

  • North America
  • Capsule Endoscopy
  • Esophagus
  • Latin America
  • Drug Delivery
  • Stomach
  • Europe
  • Patient Monitoring
  • Small Intestine
  • Japan
  • Large Intestine
  • APEJ
  • MEA

Availing the PMR Advantage

Persistence Market Research develops market studies to assess the forecast on products in an all-embracive approach. For smart pills market, a team of research consultants, trade analysts and industry veterans have created a roadmap for market size forecasting. This framework includes exclusive opinions of experts, key excerpts from dialogues between analysts and company representatives. The report also caters to the major concerns of market players and draws inferences that can provide immediate and steadfast solution. The overall smart pills market study has been developed to enable market players understand the key presumptive scenarios and plan their next steps towards future market direction.

Smart pills have emerged as a revolutionary technological innovation, bridging the gap between digital technology and healthcare. Advent of these healthcare-cum-technological devices has enabled addressing soaring demand for better monitoring and diagnostics. Smart pills have now become standard technique for non-invasive diagnosis regarding motility disorders. Physicians prefer smart pills as they enable real-time patient monitoring via remote controlling options.

Patients with Chronic Diseases to be Target Consumers of Smart Pills

Demand for drug delivery systems having integral benefits such as minimal side/adverse effects, targeted drug delivery, optimal use of API, and reduced dosage frequency has witnessed a surge. This has further led to the integration of innovative drugs, advanced technologies and medical devices into drug delivery systems, thereby resulting into the development of smart pills. People suffering from chronic diseases who require to follow specific dose of medication are likely to be target patient base for smart pills. Numerous smart pills are now being analyzed for potential application in therapeutics as well as diagnosis of several acute and chronic diseases. In addition, growing inclination toward minimally invasive surgeries has resulted into innovative techniques such as capsule endoscopy.

smart-pills-market.jpg

The elderly population is highly prone to gastrointestinal disorders. The capsule endoscopy plays an integral role in early diagnosis & proper treatment of these disorders, along with hybrid imaging technologies and new component innovations. Patients with utmost requirement for home healthcare services face challenges regarding access & use of smart pills. This has led developers and producers in increasing the accessibility & usability of these devices, facilitating the interpretation of data even for a layman. Majority of the industries are offering compatible software for collecting data over longer duration and imparting valuable information about patient health, coupled with suggestions for improving their life quality. The facility of being connected to smartphones through Bluetooth, and provision of data in user-friendly & statistical format is likely to augment demand for smart pills in the near future.

According to Persistence Market Research (PMR), global smart pills market will reflect a splendid expansion through the forecast period (2017-2026). Sales of smart pills across the globe are estimated to exceed revenues worth US$ 3,000 Mn by 2026-end.

North America to Remain Most Remunerative Market for Smart Pills

North America will continue to be the most remunerative market for smart pills, mainly driven by factors such as fast regulatory approval of new products, growing cases of colorectal cancer, and technological advancements in the healthcare sector. The market in Asia-Pacific excluding Japan (APEJ) is projected to register a robust expansion through 2026, closely trailing North America. Mandatory healthcare insurance provisions, and growing prevalence of gastrointestinal disorders and stomach cancer are primary factors influencing the market growth in APEJ. High prevalence of target disorders coupled with increasing government support is further expected to pave growth opportunities for smart pills market in APEJ.

Significant demand for minimally invasive surgeries has led toward development of innovative techniques such as the capsule endoscopy. Ease of administration and in-depth observation of gastrointestinal tract offered by capsule endoscopy has made it to replace conventional endoscopy procedures. Capsule endoscopy will be the largest application of smart pills during the forecast period. Drug delivery will also remain a remunerative application of smart pills.

Esophagus will continue to be the dominant target area for smart pills, followed by stomach. Sales of smart pills of target areas small intestine and large intestine will register the highest CAGR through 2026.

Competition Tracking

The global smart pills market is dominated by few well-established players. These players have dedicated their focus toward expansion of their product portfolio through advanced offerings of their existing smart pill versions. New market entrants are increasingly concentrating on development of breakthrough products with affordable yet advanced alternatives to their existing counterparts, in order to leverage opportunities in developing and untapped markets.

Key market participants profiled in the report include GE Healthcare, Boston Scientific Corporation, MediSafe, Proteus Digital Health, Medtronic, Bio-Images Research Limited, Olympus Corporation, Medimetrics S.A. de C.V., Given Imaging, Inc., and CapsoVision, Inc.

Company Profiles

  • CapsoVision, Inc.
  • Given Imaging, Inc.
  • Medimetrics S.A. de C.V.
  • Olympus Corporation
  • Bio-Images Research Limited
  • Medtronic
  • Proteus digital Health
  • MediSafe
  • Boston Scientific Corporation
  • GE Healthcare
  • Others.
Back To Top